Boosting Africa’s Drug Production: USP Partners African Institutions

A consortium of African institutions and the United States Pharmacopeia (USP) join forces to enhance Africa’s production of quality medical products. USP’s resources, including the USP-NF and training library, will be freely available to stakeholders across the pharmaceutical sector in Africa.

The United States Pharmacopeia (USP), in collaboration with the African Union Development Agency (AUDA –NEPAD), the Africa Centres for Disease Control and Prevention (Africa CDC), the Association of African Universities (AAU), and the Federation of African Pharmaceutical Manufacturers Associations (FAPMA) today announced a new initiative toward advancing the shared goals of increasing access to quality medicines and vaccines.

The announcement was made at the inaugural meeting of USP’s new Africa Regional Chapter, which brings critical perspectives, insights, and expertise that inform priority issues and strengthen USP’s work as a part of its official governance structure.

The United States Pharmacopeia National Formulary (USP-NF) and the USP Education training library will be available free of charge to all stakeholders in Africa working to advance the pharmaceutical ecosystem, including to regulatory authorities, laboratories, academic institutions, and manufacturers.

“Scientific quality standards and a knowledgeable workforce with ability to apply them are important enablers to build trust and confidence in African-produced medical products,” said Ronald T. Piervincenzi, Ph.D., CEO of USP. “Through our shared efforts, we aim to dramatically advance the production and availability of quality medical products for people throughout Africa.”

The USP-NF includes more than 5,000 quality standards for medicines, both chemical and biologic; active pharmaceutical ingredients (APIs); and excipients (inactive ingredients). It is one of the most comprehensive sources for medicine quality standards in the world.

“Africa’s over-reliance on pharmaceutical imports created unacceptable supply chain vulnerabilities and delays during the COVID-19 pandemic,” said Dr. Jean Kaseya, Director-General of Africa CDC. “We are committed to working with partners like USP to build African manufacturing capacity to ensure that never happens again.”

This initiative supports several African-led efforts to increase production of quality medical products, including Africa CDC’s New Public Health Order and AUDA-NEPAD’s Pharmaceutical Manufacturing Plan for Africa. AUDA-NEPAD, Africa CDC, AAU and FAPMA are collaborating in this effort by engaging their networks to maximize access to these resources.

“Development and growth of the pharmaceutical and vaccine manufacturing sector in Africa is critical to building sustainable and equitable access to health products in Africa,” said Mr. Symerre Grey Johnson, Director for Human Capital and Institutional Development of AUDA-NEPAD. “With the actualization of the African Medicines Agency coupled with the African Free Trade Agreement and high-level commitments made by the African Union and numerous heads of states, the enabling conditions are primed for this sector to grow.”

This initiative also builds upon USP’s decades-long efforts to expand access to quality medical products in Africa. Through USP’s own direct investment combined with funding from donors such as the U.S. Agency for International Development and others, USP’s global health programs have spanned collaboration and capacity building with 39 African manufacturers and 33 regional and national regulatory authorities in Africa, including the African Medicines Regulatory Harmonization program, the precursor to African Medicines Agency.

“The growth of pharmaceutical manufacturing in Africa hinges on a dynamic and robust workforce,” said Prof. Olusola Oyewole, Secretary-General of the Association of African Universities (AAU). “The development of a well-trained human resource pool with access to essential resources, such as those provided by USP, is crucial for educating tomorrow’s workforce, and transforming the continent’s pharmaceutical ecosystem.”

“Quality, including the adoption and scale up of accepted quality standards, must be at the heart of Africa’s expanding pharmaceutical sector,” said Emmanuel Mujuru, Chairperson of Federation of African Pharmaceutical Manufacturer’s Association (FAPMA). “These resources will help African manufacturers move ever closer toward a thriving, quality-focused African pharmaceutical industry.”

Tunde Alade

Tunde is a political Enthusiast who loves using technology to impact his immediate community by providing accurate data and news items for the good of the country.

Related Articles


Adblock Detected

Please consider supporting us by disabling your ad blocker